Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.UNION therapeutics has signed an agreement with TFF Pharmaceuticals for an exclusive global licence to the latter’s Thin Film Freezing (TFF) technology platform used with niclosamide drug.
The TFF platform is intended to improve the solubility and absorption of poorly water-soluble drugs, ideal for generating dry powder particles.
Under the deal, UNION will acquire an option to gain a licence to the TFF technology to be used with niclosamide, including oral and inhalation versions of the drug, potentially for Covid-19 treatment.